%0 Case Reports
%T Rapid progression of condyloma acuminatum caused by IL-17A antibody treatment: a case report.
%A Sun F
%A Yu Z
%J Front Med (Lausanne)
%V 11
%N 0
%D 2024
%M 38813385
%F 5.058
%R 10.3389/fmed.2024.1387620
%X Anti interleukin (IL)-17A therapy is a common and effective treatment for psoriasis, but there are also risks of infection. In this case, we presented a patient who experienced a swift progression of condyloma acuminatum on the genitals during psoriasis treatment with secukinumab, a human IL-17A antagonist. Through this case, we strongly suspect that anti IL-17A treatment may promote the onset and rapid progression of low-risk HPV-associated condyloma acuminatum.